Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
35.00
+0.55 (1.60%)
At close: Nov 13, 2026

SHA:603014 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,005482.3449.37442.07314.96259.82
Depreciation & Amortization
247.27247.59241.24238.25238.3201.41
Other Amortization
4.424.14.277.036.615.33
Loss (Gain) From Sale of Assets
-0.02-0.02-0.2-0.090.01-0.01
Asset Writedown & Restructuring Costs
3.413.412.753.653.015.62
Loss (Gain) From Sale of Investments
-0.99-0.99-0.22-0.11--15.86
Stock-Based Compensation
---27.1152.9671.02
Provision & Write-off of Bad Debts
1.81.818.6921.1837.23-0.03
Other Operating Activities
-99.37-27.97-6.79-25.11-19.1446.71
Change in Accounts Receivable
22.5522.55-120.6127.5-188.05-222.91
Change in Inventory
-83.9-73.81142.77-262.4-117.45-101.94
Change in Accounts Payable
133.83133.83-170.24-196.98413.24257.92
Change in Other Net Operating Assets
12.061.9610.97---
Operating Cash Flow
1,245793.71572.3288.14727.33504.89
Operating Cash Flow Growth
63.75%38.69%98.62%-60.38%44.06%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-200.15-159.85-179.3-232.81-279.8-401.25
Sale of Property, Plant & Equipment
-2.410.313.886.878.116.88
Investment in Securities
-1,286-1,363-259.9137.5410.25.58
Other Investing Activities
43.2130.94560.8919.470.15
Investing Cash Flow
-1,445-1,492-379.34-187.51-242.03-378.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--3.186.64480.07677.95
Total Debt Issued
134.4-3.186.64480.07677.95
Short-Term Debt Repaid
----41.8-1,238-765.02
Long-Term Debt Repaid
--8.76-8.26-7.48-82.69-
Lease Payments
-8.76-8.76-8.26-7.48-82.69-
Total Debt Repaid
-8.76-8.76-8.26-49.28-1,321-765.02
Net Debt Issued (Repaid)
125.63-8.76-5.08-42.63-840.82-87.08
Issuance of Common Stock
-1,216--624.21-
Common Dividends Paid
-304.6-65.83--0.49-18.84-42.71
Other Financing Activities
-12.4-98.22-10.36-4.2313.33-116.19
Financing Cash Flow
-191.361,043-15.44-47.35-222.11-245.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-10.40.19-0.510.843.26-0.9
Net Cash Flow
-401.9345.14177.0254.11266.45-120.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,045633.8639355.33447.53103.64
Free Cash Flow Growth
74.43%61.29%610.28%-87.64%331.80%-
Free Cash Flow Margin
19.35%16.82%10.90%1.57%13.06%3.56%
Free Cash Flow Per Share
1.691.601.060.151.230.29
Levered Free Cash Flow
-153.21500.49361.2694.07249.99-
Unlevered Free Cash Flow
-152.92500.96361.6394.6261.44-
Free Cash Flow After Leases
1,036625.1384.7447.85364.84103.64

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
434.05318.55343.06302.29203.49265.76
Change in Working Capital
83.4983.49-136.81-425.8493.38-69.13